YF-VAX 1 dose vials
Ended Awarded
- Contract number
- SPE2DB25FZX20
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $55,671
Award facts
- Contract value 100% obligated
- $55,671.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $55,671 to DMS Pharmaceutical Group Inc. for the supply of YF-VAX 1 dose vials, a yellow fever vaccine product. This firm fixed-price delivery order, issued on June 7, 2025, with a completion date of June 30, 2025, carries no set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, will perform the work at its Park Ridge location. The company leverages its position as a woman-owned small business to compete in federal procurement markets while maintaining an extensive pharmaceutical product portfolio.
This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, valued at $499.999 billion and valid through November 2026. This IDC framework enables the agency to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items, including branded and generic prescription drugs, biologics, over-the-counter medications, and medical consumables to support military health facilities nationwide. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, providing direct distribution of vaccines and pharmacy-related products to Department of Defense healthcare sites globally.
Quick answers
Who was awarded contract SPE2DB25FZX20?
SPE2DB25FZX20 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on June 7, 2025.
How much is contract SPE2DB25FZX20 worth?
The government has obligated $55,671 on SPE2DB25FZX20.
Is contract SPE2DB25FZX20 an order under another contract?
Yes. SPE2DB25FZX20 is a delivery order under SPE2DB20D9135, an indefinite delivery contract.
Was contract SPE2DB25FZX20 competed?
The extent of competition for SPE2DB25FZX20 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award